Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis.
AUTOR(ES)
Abbott, R J
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1028659Documentos Relacionados
- Low dose interferon-alpha is safe in patients with myasthenia gravis.
- Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C
- Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
- Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.
- Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.